Sepsis is a leading cause of death in children, and an early diagnosis that improves outcomes is less likely in children who are treated in general Emergency D…

SepsisDiagnosisEmergencies

~Estimated

~$10 – $6,250

University of Colorado, DenverNCT07051668

Phase 1

A Phase 1b Study to Assess the Safety, Tolerability and Pharmacokinetics of OPT101 in Patients With Community Acquired Pneumonia (CAP) With Sepsis

OPT101-100-40 is a multicenter, randomized, placebo-controlled, multiple-ascending-dose, sequential-group, investigator- and participant-blinded, sponsor-unbli…

SepsisCommunity Acquired Pneumonia (CAP)

~Estimated

~$10 – $8,750

Op-T LLCNCT06669403

← PreviousPage 6 of 6Next →